←
HMS HCP1,089 posts
HMS HCP avatar

HMS HCP

@HMSHCP

The @harvardmed department of health care policy seeks to improve public health through comprehensive health policy.

◷ Joined January 2017▧ 349 Photos and videos
HMS HCP avatar
HMS HCP@HMSHCP·Feb 27

📣Exciting news! Professor Alex Luedtke has been named a 2026 COPSS Emerging Leader Award winner! The award recognizes early-career statistical scientists whose leadership and scholarship are helping to shape the future of the field. Congratulations, Alex! 🎉 @COPSSNews

HMS HCP avatar
HMS HCP@HMSHCP·20 Oct 2025

The paper is joint work with Profs. Ambarish Chattopadhyay and Carl Morris, and revisits & extends Morris's Finite Selection Model to improve randomized experiments/clinical trials.

HMS HCP avatar
HMS HCP@HMSHCP·4 Jun 2025

Congratulations to @Michael_Chernew (Reinhardt Distinguished Career Award) and @FangliGeng (Outstanding Dissertation) on their @AcademyHealth awards! Your leadership and research are transforming the future of health services and policy. 🏆👏 #HealthPolicy

AcademyHealth is excited to announce the recipients of the #ARM25 awards, which recognize significant contributions to the fields of health services research and health policy. Learn more about the recipients here: academyhealth.org/node/24135

Post attachment
USC Schaeffer avatar
⟳ HMS HCP retweeted
USC Schaeffer@USCSchaeffer·30 Apr 2025

Pharmaceutical tariffs could raise prices and reduce innovation, says @DrWmPadula in an interview for @ABC7. Long-term, "Americans could pay by not having the availability of new innovative medications." abc7.com/post/tariff-uncerta…

JAMA Health Forum avatar
⟳ HMS HCP retweeted
JAMA Health Forum@JAMAHealthForum·2 May 2025

Universal annual depression screening for adolescents in primary care is cost-effective, especially if health systems improve access to telemedicine behavioral health, reduce treatment costs, or enhance treatment effectiveness. ja.ma/4jY1ebg

Michael McWilliams avatar
⟳ HMS HCP retweeted
Michael McWilliams@JMichaelMcW·28 Mar 2025

Two-part article in @Health_Affairs Forefront with my thoughts on improving risk adjustment Actually more of a synthesis of great work and insights from the field and a set of recommendations that follows from considering it all together. This is an area where academia/health econ/HSR – both in the US and internationally – has really shined in advancing the science. My hope is that this piece helps folks think through what is a very thorny and pressing topic. Links: Part 1 - healthaffairs.org/content/fo… Part 2 - healthaffairs.org/content/fo… Main points: The goal is not to maximize fit (predictive accuracy). Fit is important but does not define selection incentives alone, and there are important tradeoffs with gaming and cost control incentives. Better fit does not mean a better system. The goal is to establish a set of incentives that best advances an economic/social objective (e.g., efficiency), as opposed to a statistical one (e.g., R2). There are a ton of ideas out there. Some are better than others, but key is no single idea will get us what we want. A combination of strategies is needed. Good news is that a lot of thoughtful people have done a lot of great work, so “we have the technology” (though the tech may be less flashy than a bionic man). The inputs are critical. There are some very sensible measures that can be taken to scale back the more manipulable elements of the HCC model to mitigate coding incentives, while keeping less problematic conditions and sources of diagnoses. Don’t need to throw the baby out with the bathwater, but the baby needs a bath. Measures to scale back the HCC model will exacerbate selection incentives to some extent, motivating the addition of inputs from less manipulable data sources. Independently collected survey data hold promise, and existing surveys can be built upon. A future system in which data on a range of inputs are independently collected for a sample of a plan's or ACO’s population is a worthy aspiration (and we should want to collect those data anyway for monitoring and research purposes). Drug-based condition categories may also be helpful, and there is precedent in other systems and countries, but need to mindful of prescribing incentives (an area in need of further study). Machine learning is great. But important to apply it to candidate inputs that offer desired incentives. Reinsurance is risk adjustment’s BFF. It offers nearly free fit by capping extreme losses (and extreme profits in a “two-sided” scheme) where under/overpredictions are most severe (contributions to selection incentives potentially strongest), without eroding cost control incentives much because it only affects a very small % of enrollees. It also helps mitigate coding incentives for some nuanced reasons. Put this all together, and we could have a MUCH better risk adjustment system. The piece includes links to some great work and thinking by Tom McGuire, Rick Kronick, @SherriRose, @MikeGeruso, @richardvankleef, @Michael_Chernew, Jeah Jung, @MelindaBBunitin, @MeghanBellerose, @nirudatta, Alan Zaslavsky, Randy Ellis, Sonja Schillo, and Sherry Glied, among others It was also fun talking to Rob Lott about some of this on A Health Podyssey: healthaffairs.org/do/10.1377…

Anupam Jena avatar
⟳ HMS HCP retweeted
Anupam Jena@AnupamBJena·16 Jan 2025

Very interesting study from the Michigan folks. You could have predicted it was from them based on the topic and cleverness of the finding @jdimick1

JAMA@JAMA_current16 Jan 2025

Centers for Medicare & Medicaid Services (@CMSGov) coding changes linking abdominal wall hernia size to reimbursement were associated with an increase in documented hernia size by surgeons. ja.ma/42gdA96

Post attachment